Announcements Trials
Browse Landscape

Phase

Phase NA 54Phase 2 3Phase 3 2Phase 2/3 1Phase 1 1

Status

Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3Breast 3Gastrointestinal 2Other hematologic neoplasm 1Gynecologic 1Dermatologic 1

Conditions

Breast Neoplasms 2Prostatic Neoplasms 1Motor Activity 1Anatomic Stage I Breast Cancer American Joint Committee on Cancer (AJCC) v8 1

Interventions

Trastuzumab 347Paclitaxel 309Cyclophosphamide 286Docetaxel 267Carboplatin 215Capecitabine 214Letrozole 185Fulvestrant 176Doxorubicin 166Bevacizumab 136Anastrozole 120Tamoxifen 117pertuzumab 112pembrolizumab 112Epirubicin 110exemestane 107Vinorelbine 106Gemcitabine 106Albumin-Bound Paclitaxel 92Lapatinib 84130-nm albumin-bound paclitaxel 83Radiotherapy 79palbociclib 75eribulin 73Cisplatin 69pyrotinib 65Taxes 65Everolimus 55Goserelin 50Drug Therapy 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Methods × Breast × Clear all
NCT01621659 2026-05-11

TITAN

University of Alberta

Phase 2 Active not recruiting
80 enrolled
Breast

Breast Neoplasms, Motor Activity

NCT06113016 2025-07-08

PROFFi

Jonsson Comprehensive Cancer Center

Phase 2 Recruiting
164 enrolled
Breast

Anatomic Stage I Breast Cancer American Joint Committee on Cancer (AJCC) v8

NCT06049355 2025-05-29

EMBRACE: Exercising Together

OHSU Knight Cancer Institute

Phase 2 Recruiting
400 enrolled
BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡